| Bridging the gaps: A cross-species approach to PD-1 and OX40 combination immunotherapy M Sandey, D Ruiz, J Marable, D Bedi, P Agarwal Cancer Research 84 (6_Supplement), 3736-3736, 2024 | | 2024 |
| The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro TA Higgins, DJ Patton, IM Shimko-Lofano, TL Eller, R Molinari, M Sandey, ... Cells 13 (4), 351, 2024 | | 2024 |
| miRNAs: Potential as biomarkers and therapeutic targets for cancer A Chakrabortty, DJ Patton, BF Smith, P Agarwal Genes 14 (7), 1375, 2023 | 30 | 2023 |
| Exploration of multiple immunotherapy modalities in ostesarcoma AA Ismail, DJ Patton, TA Higgins, M Sandey, BF Smith, P Agarwal Cancer Research 83 (7_Supplement), 2339-2339, 2023 | | 2023 |
| Development of OX40 agonists for canine cancer immunotherapy D Ruiz, C Haynes, J Marable, C Pundkar, RL Nance, D Bedi, P Agarwal, ... Iscience 25 (10), 2022 | 3 | 2022 |
| Abstract A039: Transcriptomic analysis of canine osteosarcoma from a precision medicine perspective reveals limitations of differential gene expression studies RL Nance, S Cooper, D Starenki, X Wang, M Sandey, J Koehler, ... Cancer Research 82 (10_Supplement), A039-A039, 2022 | | 2022 |
| Transcriptomic analysis of canine osteosarcoma from a precision medicine perspective reveals limitations of differential gene expression studies RL Nance, SJ Cooper, D Starenki, X Wang, B Matz, S Lindley, AN Smith, ... Genes 13 (4), 680, 2022 | 6 | 2022 |
| Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines MD Hogans, WP Kretzschmar, TA Higgins, A Chakrabortty, RL Nance, ... Advances in Virology 2022 (1), 3658970, 2022 | | 2022 |
| Identification of canine circulating miRNAs as tumor biospecific markers using Next-Generation Sequencing and Q-RT-PCR P Agarwal, MP Crepps, NA Stahr, WP Kretzschmar, HC Harris, N Prasad, ... Biochemistry and biophysics reports 28, 101106, 2021 | 11 | 2021 |
| In vitro functional genetic modification of canine adenovirus type 2 genome by CRISPR/Cas9 AM Sajib, P Agarwal, DJ Patton, RL Nance, NA Stahr, WP Kretzschmar, ... Laboratory Investigation 101 (12), 1627-1636, 2021 | 3 | 2021 |
| Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients J Marable, D Ruiz, AK Jaiswal, R Bhattacharya, R Pantazes, P Agarwal, ... Scientific Reports 11 (1), 20763, 2021 | 13 | 2021 |
| Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients P Agarwal, EA Gammon, M Sandey, SS Lindley, JW Koehler, BM Matz, ... Heliyon 7 (2), 2021 | 5 | 2021 |
| Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors AM Sajib, M Sandey, S Morici, B Schuler, P Agarwal, BF Smith Plos one 15 (11), e0240807, 2020 | 1 | 2020 |
| A method for isolating RNA from canine bone R Nance, P Agarwal, M Sandey, D Starenki, J Koehler, AM Sajib, ... Biotechniques 68 (6), 311-317, 2020 | 6 | 2020 |
| A method for isolating RNA from canine bone V. 2 R Nance, P Agarwal, M Sandey, D Starenki, J Koehler, AM Sajib, ... | | 2020 |
| Identification of promoters for targeted gene expression in tumors AM Sajib, M Sandey, S Morici, B Schuler, P Agarwal, B Smith Cancer Research 79 (13_Supplement), 4778-4778, 2019 | | 2019 |
| Precise Genetic Modification of Canine Adenovirus Type 2 (CAV2) Genome by CRISPR/CAS9 AM Sajib, R Nance, W Kretzschmar, P Agarwal, BF Smith MOLECULAR THERAPY 27 (4), 104-104, 2019 | | 2019 |
| Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation P Agarwal, P DeInnocentes, RC Bird In Vitro Cellular & Developmental Biology-Animal 54, 658-665, 2018 | 3 | 2018 |
| Tumor Activity of Candidate Promoters in Canine Tumors BF Smith, AM Sajib, M Sandey, S Morici, B Schuler, P Agarwal MOLECULAR THERAPY 26 (5), 211-211, 2018 | | 2018 |
| Identification of Circulatory miRNAs in Canine Cancer Patient Liquid Biopsies P Agarwal, MP Crepps, NA Stahr, EC Graff, BF Smith MOLECULAR THERAPY 26 (5), 149-150, 2018 | | 2018 |
Maninder SandeyAssistant Professor, Auburn University在 auburn.edu 的电子邮件经过验证
